|
Volcano Corporation
Announces Preliminary Record Revenues for Fourth Quarter 2009
Total
Year Revenues are Expected to Exceed Prior Guidance
|
 |
January 11, 2010 -- San Diego -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacture and sales
of products for the diagnosis and treatment of coronary and peripheral
artery disease, said today that it expects total revenues for fiscal
2009 will be approximately $228.0 million, with revenues in the fourth
quarter of fiscal 2009 expected to be approximately $71.0 million.
Iintravascular
Ultrasound
sees inside the artery |
|
The revenue expectations
for fiscal 2009 compare with the company's prior guidance for
fiscal 2009 revenues of $218.0-$223.0 million, and reflect
year-over-year revenue growth of approximately 33 percent.
The expectations for revenues in the fourth quarter of 2009
represent an increase of approximately 44 percent over revenues
in the fourth quarter of 2008. The results for the full year
and fourth quarter of 2009 include revenues of approximately
$18.0 million and $5.8 million, respectively, from Axsun Technologies,
Inc., which Volcano acquired at the end of 2008, and for which
the company recorded no meaningful revenues in either period
during 2008.
|
"Our financial performance for the quarter was driven by strong growth across our core businesses and in our key geographies. In particular, we saw growth in capital equipment sales in the U.S. and Europe and continued adoption of our IVUS (Intravascular Ultrasound) and FM (Functional Measurement) disposables. In addition, we benefitted from our going direct transition in Japan," noted
Scott Huennekens, president and chief executive officer of Volcano.
The company said it was providing the updated revenue projections for 2009 in advance of meetings with the investment community and a presentation at the 28th Annual J.P. Morgan Healthcare Conference this week. The company's presentation will occur at 2 p.m., Pacific Standard Time (5 p.m. Eastern Standard Time), on Tuesday, January 12, and will be available through the conference website at http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink?ticker=VOLC and via the company's website at www.volcanocorp.com. The company's fourth quarter and full-year 2009 operating and financial performance and guidance for fiscal 2010 will be provided in a press release, as well as in a conference call and webcast open to all interested parties, in early March. Details of the earnings release date, conference call and webcast will be provided in a subsequent release.
About Volcano
Volcano Corporation (Nasdaq: VOLC)
offers a broad suite of devices designed to facilitate endovascular
procedures, enhance the diagnosis of vascular and structural heart
disease and guide optimal therapies. The company's intravascular
ultrasound (IVUS) product line includes ultrasound consoles that
can be integrated directly into virtually any modern cath lab. Volcano
IVUS offers unique features, including both single-use phased array
and rotational IVUS imaging catheters, and advanced functionality
options, such as VH(R) IVUS tissue characterization and ChromaFlo(R).
Volcano also provides functional measurement (FM) consoles and single-use
pressure and flow guide wires and is developing a line of ultra-high
resolution Optical Coherence Tomography and Forward-Looking IVUS
systems and catheters. Currently, more than 4,700 Volcano IVUS and
FM systems are installed worldwide, and more than half of Volcano's
revenues are derived from outside the United States. Through its
wholly-owned subsidiary, Axsun Technologies, Volcano also develops
and manufactures optical monitors, lasers and optical engines used
in telecommunications, spectroscopy and other industrial applications.
For more information, visit the company's website at http://www.volcanocorp.com Forward-Looking Statements
This
press release contains forward-looking statements within the meaning of the
U.S. Private Securities Litigation Reform
Act of 1995. Statements in this press release regarding Volcano's business
that are not historical facts may be "forward-looking statements" that involve
risks and uncertainties. Specifically, statements concerning Volcano's expected
revenues and revenue growth for the fourth quarter and fiscal year ended
December 31, 2009, are forward looking statements involving risks and uncertainties
as Volcano's 2009 financial results, including revenues, have not been audited.
These statements are being made prior to the completion of Volcano's accounting
close procedures for the fiscal year ended December 31, 2009, and are therefore
subject to modification. Forward-looking statements are based on management's
current, preliminary expectations and are subject to risks and uncertainties,
which may cause Volcano's results to differ materially from the statements
contained herein. The potential risks and uncertainties that could cause
actual results to differ from the results predicted are detailed in the company's
reports and other filings made with the Securities and Exchange Commission.
Undue reliance should not be placed on forward-looking statements, which
speak only as of the date they are made. Volcano undertakes no obligation
to update publicly any forward-looking statements to reflect new information,
events or circumstances after the date they were made, or to reflect the
occurrence of unanticipated events.
Source: Volcano
Corporation
|
